172 related articles for article (PubMed ID: 12531890)
21. Plasma phospholipid transfer protein-mediated reactions are impaired by hypochlorite-modification of high density lipoprotein.
Pussinen PJ; Metso J; Keva R; Hirschmugl B; Sattler W; Jauhiainen M; Malle E
Int J Biochem Cell Biol; 2003 Feb; 35(2):192-202. PubMed ID: 12479869
[TBL] [Abstract][Full Text] [Related]
22. Mast cell tryptase degrades HDL and blocks its function as an acceptor of cellular cholesterol.
Lee M; Sommerhoff CP; von Eckardstein A; Zettl F; Fritz H; Kovanen PT
Arterioscler Thromb Vasc Biol; 2002 Dec; 22(12):2086-91. PubMed ID: 12482839
[TBL] [Abstract][Full Text] [Related]
23. Phospholipid transfer protein (PLTP) causes proteolytic cleavage of apolipoprotein A-I.
Jauhiainen M; Huuskonen J; Baumann M; Metso J; Oka T; Egashira T; Hattori H; Olkkonen VM; Ehnholm C
J Lipid Res; 1999 Apr; 40(4):654-64. PubMed ID: 10191289
[TBL] [Abstract][Full Text] [Related]
24. Cell-associated and extracellular phospholipid transfer protein in human coronary atherosclerosis.
O'Brien KD; Vuletic S; McDonald TO; Wolfbauer G; Lewis K; Tu AY; Marcovina S; Wight TN; Chait A; Albers JJ
Circulation; 2003 Jul; 108(3):270-4. PubMed ID: 12835223
[TBL] [Abstract][Full Text] [Related]
25. Human plasma phospholipid transfer protein causes high density lipoprotein conversion.
Jauhiainen M; Metso J; Pahlman R; Blomqvist S; van Tol A; Ehnholm C
J Biol Chem; 1993 Feb; 268(6):4032-6. PubMed ID: 8440695
[TBL] [Abstract][Full Text] [Related]
26. Transgenic mice expressing human phospholipid transfer protein have increased HDL/non-HDL cholesterol ratio.
Albers JJ; Tu AY; Paigen B; Chen H; Cheung MC; Marcovina SM
Int J Clin Lab Res; 1996; 26(4):262-7. PubMed ID: 9007618
[TBL] [Abstract][Full Text] [Related]
27. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein.
Tu AY; Nishida HI; Nishida T
J Biol Chem; 1993 Nov; 268(31):23098-105. PubMed ID: 8226827
[TBL] [Abstract][Full Text] [Related]
28. Modulation of the phospholipid transfer protein-mediated transfer of phospholipids by diacylglycerols.
Lalanne F; Motta C; Pafumi Y; Lairon D; Ponsin G
J Lipid Res; 2001 Jan; 42(1):142-9. PubMed ID: 11160376
[TBL] [Abstract][Full Text] [Related]
29. Overexpression and deletion of phospholipid transfer protein reduce HDL mass and cholesterol efflux capacity but not macrophage reverse cholesterol transport.
Kuwano T; Bi X; Cipollari E; Yasuda T; Lagor WR; Szapary HJ; Tohyama J; Millar JS; Billheimer JT; Lyssenko NN; Rader DJ
J Lipid Res; 2017 Apr; 58(4):731-741. PubMed ID: 28137768
[TBL] [Abstract][Full Text] [Related]
30. The impact of phospholipid transfer protein (PLTP) on HDL metabolism.
Huuskonen J; Olkkonen VM; Jauhiainen M; Ehnholm C
Atherosclerosis; 2001 Apr; 155(2):269-81. PubMed ID: 11254896
[TBL] [Abstract][Full Text] [Related]
31. Role of phospholipid transfer protein and prebeta-high density lipoproteins in maintaining cholesterol efflux from Fu5AH cells to plasma from insulin-resistant subjects.
Dullaart RP; van Tol A
Scand J Clin Lab Invest; 2001 Feb; 61(1):69-74. PubMed ID: 11300613
[TBL] [Abstract][Full Text] [Related]
32. Triglyceride-enrichment of high density lipoproteins enhances their remodelling by phospholipid transfer protein.
Rye KA; Jauhiainen M; Barter PJ; Ehnholm C
J Lipid Res; 1998 Mar; 39(3):613-22. PubMed ID: 9548593
[TBL] [Abstract][Full Text] [Related]
33. Phospholipid transfer protein is expressed in cerebrovascular endothelial cells and involved in high density lipoprotein biogenesis and remodeling at the blood-brain barrier.
Chirackal Manavalan AP; Kober A; Metso J; Lang I; Becker T; Hasslitzer K; Zandl M; Fanaee-Danesh E; Pippal JB; Sachdev V; Kratky D; Stefulj J; Jauhiainen M; Panzenboeck U
J Biol Chem; 2014 Feb; 289(8):4683-98. PubMed ID: 24369175
[TBL] [Abstract][Full Text] [Related]
34. The role of plasma phospholipid transfer protein (PLTP) in HDL remodeling in acute-phase patients.
Pussinen PJ; Metso J; Malle E; Barlage S; Palosuo T; Sattler W; Schmitz G; Jauhiainen M
Biochim Biophys Acta; 2001 Sep; 1533(2):153-63. PubMed ID: 11566452
[TBL] [Abstract][Full Text] [Related]
35. Elevation of systemic PLTP, but not macrophage-PLTP, impairs macrophage reverse cholesterol transport in transgenic mice.
Samyn H; Moerland M; van Gent T; van Haperen R; Grosveld F; van Tol A; de Crom R
Atherosclerosis; 2009 Jun; 204(2):429-34. PubMed ID: 19100548
[TBL] [Abstract][Full Text] [Related]
36. Molecular mechanism of reverse cholesterol transport: reaction of pre-beta-migrating high-density lipoprotein with plasma lecithin/cholesterol acyltransferase.
Nakamura Y; Kotite L; Gan Y; Spencer TA; Fielding CJ; Fielding PE
Biochemistry; 2004 Nov; 43(46):14811-20. PubMed ID: 15544352
[TBL] [Abstract][Full Text] [Related]
37. The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion.
Lusa S; Jauhiainen M; Metso J; Somerharju P; Ehnholm C
Biochem J; 1996 Jan; 313 ( Pt 1)(Pt 1):275-82. PubMed ID: 8546695
[TBL] [Abstract][Full Text] [Related]
38. Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid.
Lindstedt L; Lee M; Castro GR; Fruchart JC; Kovanen PT
J Clin Invest; 1996 May; 97(10):2174-82. PubMed ID: 8636396
[TBL] [Abstract][Full Text] [Related]
39. Phospholipid transfer protein is present in human atherosclerotic lesions and is expressed by macrophages and foam cells.
Desrumaux CM; Mak PA; Boisvert WA; Masson D; Stupack D; Jauhiainen M; Ehnholm C; Curtiss LK
J Lipid Res; 2003 Aug; 44(8):1453-61. PubMed ID: 12730304
[TBL] [Abstract][Full Text] [Related]
40. Matrix metalloproteinases-3, -7, and -12, but not -9, reduce high density lipoprotein-induced cholesterol efflux from human macrophage foam cells by truncation of the carboxyl terminus of apolipoprotein A-I. Parallel losses of pre-beta particles and the high affinity component of efflux.
Lindstedt L; Saarinen J; Kalkkinen N; Welgus H; Kovanen PT
J Biol Chem; 1999 Aug; 274(32):22627-34. PubMed ID: 10428843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
